| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Leukemia | |||||
| Lymphoma | |||||
| Lymphoproliferative Disorder | |||||
| Small Intestine Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Duodenal Neoplasms | |||||
| Ileal Neoplasms | |||||
| Intestinal Neoplasms | |||||
| Jejunal Neoplasms | |||||
| Lymphoproliferative Disorders | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Duodenal Diseases | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Ileal Diseases | |||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Intestinal Diseases | |||||
| Jejunal Diseases | |||||
| Lymphatic Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| 4 | Interventions listed in this trial | ||||
| everolimus | |||||
| laboratory biomarker analysis | |||||
| 5 | More general drug interventions related to this trial | ||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| Mayo Clinic | |||||
| National Cancer Institute (NCI) | |||||
|
